2-cohort study of adult patients with severe Hemophilia A in Greece (HAMLET)
This study is a prospective, single center, observational, 2-cohort study of adult patients with severe Hemophilia A. There is no randomization procedure and all patients will be treated as per usual clinical practice. Patients will be followed up for 18 months after enrolment.
- Patients diagnosed with severe Hemophilia A. - Age ≥18 years old - Patients able to read and write - Patients receiving Factor VIII substitute therapy, either on-demand or as secondary prophylaxis. - Patients under the same therapeutic strategy (On Demand or Secondary Prophylaxis) for at least 6 months prior to enrolment.
- Patients that have developed inhibitors against factor VIII. - Patients participating in an investigational program with interventions outside of routine clinical practice.
many locations, Greece
E-mail: [email protected]
Phone: (+) 1-888-8422937
Prospective, observational, 2-cohort study of adult patients with severe Hemophilia A in Greece. Cost,clinical outcomes and quality of life comparison between on demand and secondary prophylaxis treatment strategies